Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/1965
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOKPALA, I. E.-
dc.contributor.authorSHOKUNBI, W. A.-
dc.contributor.authorSALIU, I.-
dc.contributor.authorAKINBOYE, D. O.-
dc.contributor.authorESSIEN, E. M.-
dc.date.accessioned2023-02-21T10:36:30Z-
dc.date.available2023-02-21T10:36:30Z-
dc.date.issued1993-12-
dc.identifier.citationAfr. J. Med. med. Sci. (1993) 22(4): 73-76en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/1965-
dc.descriptionArticleen_US
dc.description.abstractOne hundred and four Nigerians with lymphoproliferative malignancies were tested for antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and 2). All the patients with high grade lymphomas in this series were seronegative for HIV-1 and 2. Only 1 of the 104 patients had antibody to HIV-1, and none had antibody to HIV-2. Although the single positive result would suggest a higher HIV-1 seropositivity rate among the patients compared with the general Nigerian population, it should be interpreted with caution. This preliminary data emphasizes the need for an urgent countrywide study of the problem among this category of patients in Nigeria in view of the low prevalence rate of HIV-1 and 2 in the country.en_US
dc.description.sponsorshipCollege of Medicineen_US
dc.language.isoenen_US
dc.publisherSpectrum Books Limiteden_US
dc.subjectAntibodiesen_US
dc.subjectHIVen_US
dc.subjectPatientsen_US
dc.subjectNigeriansen_US
dc.titleHIV seropositivity in Nigerians with lymphoproliferative malignanciesen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Okpala et al_Hiv_1993.pdfArticle7.06 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.